⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27907214 | 0.97 | LCK (0.48) | — | |
| SCHEMBL27978541 | 0.97 | LCK (0.48) | — | |
| SCHEMBL28280322 | 0.97 | LCK (0.48) | — | |
| SCHEMBL7863876 | 0.97 | LCK (0.48) | — | |
| SCHEMBL7872063 | 0.97 | LCK (0.48) | — | |
| SCHEMBL28982429 | 0.97 | LCK (0.48) | — | |
| SCHEMBL27907215 | 0.97 | LCK (0.48) | — | |
| SCHEMBL151988 | 0.97 | — | — | |
| SCHEMBL11323767 | 0.97 | LCK (0.48) | — | |
| SCHEMBL42455 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116710091-A | Membrane iron transporter inhibitors for the treatment of myelodysplastic syndrome (MDS) | 威佛（国际）股份公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-110785417-B | Membrane iron transporter inhibitor salts | 威佛（国际）股份公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-114765955-A | Methods and compositions for treating sickle cell disease with an iron transporter inhibitor (VIT-2763) | 威佛（国际）股份公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-114668761-A | Novel ferroportin inhibitors | 威佛（国际）股份公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-108290878-B | Novel ferroportin inhibitors | 威佛（国际）股份公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114302882-A | Ferroportin inhibitor for treating transfusion-dependent BETA-thalassemia (TDT) | 威佛（国际）股份公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114269740-A | Ferroportin inhibitors for the prevention and treatment of renal injury | 威佛（国际）股份公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-110785417-A | Membrane ferroportin inhibitor salts | 威佛（国际）股份公司 | 2020-02-11 | — | — | CN | disclosed |
| US-9943498-B2 | Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias | VIFOR (INTERNATIONAL) AG (CH) | 2018-04-17 | — | — | US | disclosed |
| CN-103492028-B | Sulfonaminoquinoline hepcidin antagonists | 维福（国际）股份公司 | 2017-02-08 | — | — | CN | disclosed |
| EP-0719839-B1 | Phthalocyanine compounds and optical recording media comprising them | MITSUI CHEMICALS INC (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-6242474-B1 | SULFONYLCARBAMOYLALKYLIMIDAZOLE DERIVATIVES; ANTIDIABETIC AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| US-6166219-A | Benzimidazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| CN-1268942-A | Sulfonamide compounds and medicinal use thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 2000-10-04 | — | — | CN | disclosed |
| EP-1000932-A1 | AROMATIC RING DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-17 | — | — | EP | disclosed |
| EP-0995742-A1 | SULFONAMIDE COMPOUNDS AND MEDICINAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-26 | — | — | EP | disclosed |
| CN-1211238-A | Benzimidazole derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1999-03-17 | — | — | CN | disclosed |
| EP-0882718-A1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5693396-A | NEAR INFRARED LIGHT ABSORBERS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-12-02 | — | — | US | disclosed |
| EP-0719839-A2 | Phthalocyanine compounds and optical recording media comprising them | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-07-03 | — | — | EP | disclosed |